Pancytopenia in a patient with scleroderma treated with infliximab.
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D010198:Pancytopenia / Q000139:chemically induced*; D012595:Scleroderma, Systemic / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab